Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies

Diagnostic assay for anti-von Willebrand Factor cleaving protease (ADAMTS13) antibodies

US Patent 7943326 · Granted May 17, 2011

Estimated economic value: $73,768,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TFPI inhibitors and methods of use2023
Subcutaneous administration of ADAMTS132023
Viral vectors encoding recombinant FVIII variants with increased expression for 2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Anti-MIF immunohistochemistry2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive cris2021
Subcutaneous administration of ADAMTS132021
Compositions of human prothrombin and activated factor X for improving hemostasi2021
ADAMTS13-containing compositions having thrombolytic activity2021
ADAMTS13-containing compositions having thrombolytic activity2021